Skip to main content

Advertisement

Table 2 Patients receiving invasive procedures, time to management decision, and diagnostic procedures for the Pre-EBUS cohort compared to the Post-EBUS cohort

From: Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study

  Pre-EBUS cohort (n = 234) Post-EBUS cohort (n = 326) p
  n (%)a n (%)a  
Invasive procedures    
 Bronchoscopy 135 (57.7) 131 (40.2) <0.001**
 CT-TTNA 92 (39.3) 95 (29.1) 0.012*
 EBUS 0 (0) 90 (27.6) <0.001**
 Thoracentesis 26 (11.1) 24 (7.4) 0.125
 Other invasive procedures 30 (12.8) 47 (14.4) 0.588
 Other surgical procedures 9 (3.8) 13 (4.0) 0.932
 Mediastinoscopy 1 (0.4) 3 (0.9) 0.644d
Time to management decisionc    
  ≤ 28 days 154 (66.7) 245 (75.9)  
  > 28 days 77 (33.3) 78 (24.1) 0.018*
  Median (IQR) Median (IQR)  
Time to management decision (days)c 17 (24) 13 (21) 0.070d
Number of invasive diagnostic proceduresb 1 (0) 1 (0) 0.842e
  1. Thoracentesis: thoracentesis, pleural effusion drainage, pleural biopsy
  2. Other invasive procedures: FNA, US-FNA, EUS-FNA, biopsy other, CT biopsy other
  3. Other surgical therapeutic/diagnostic procedures: surgery for brain metastasis, bone marrow trephine, spinal lesions
  4. *p < 0.05, **p < 0.01
  5. aNumber of patients
  6. bNumber per patient
  7. cExcludes 6 patients with no date of presentation available – unable to establish time to management decision
  8. dFisher’s exact test
  9. eMann–Whitney U test; all other tests except d are Pearson’s chi squared test